» Journals » J Cachexia Sarcopenia Muscle

Journal of Cachexia, Sarcopenia and Muscle

The Journal of Cachexia, Sarcopenia and Muscle is a peer-reviewed publication dedicated to advancing the understanding and management of cachexia, sarcopenia, and muscle wasting disorders. It provides a platform for researchers and clinicians to share cutting-edge research, clinical trials, and innovative therapies aimed at improving the quality of life for individuals affected by these conditions.

Details
Abbr. J Cachexia Sarcopenia Muscle
Start 2010
End Continuing
Frequency Quarterly
p-ISSN 2190-5991
e-ISSN 2190-6009
Country Germany
Language English
Metrics
h-index / Ranks: 3121 100
SJR / Ranks: 676 2816
CiteScore / Ranks: 804 13.00
JIF / Ranks: 563 8.9
Recent Articles
21.
Zhang Y, Wang T, Wang Z, Shi X, Jin J
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13747. PMID: 40034097
Skeletal muscle is the most abundant tissue in the human body and is responsible for movement, metabolism, energy production and longevity. Muscle atrophy is a frequent complication of several diseases...
22.
Kambic T, Debevec T, Lainscak M
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13769. PMID: 40034074
No abstract available.
23.
Shahbazi S, Shahbazi E, Zayeri F, Vahdat Shariatpanahi Z
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13753. PMID: 40034063
Background: Endothelial damage induces myofibrillar breakdown and muscle degradation in COVID-19 infection. There is a relationship between increased endothelin-1 synthesis and sarcopenia. We evaluated the preventive effect of early bosentan...
24.
Wei S, Park S, Choi E, Jang I, Zhang Y, Xue Y, et al.
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13745. PMID: 40026116
Background: β2-Microglobulin (B2M) has garnered considerable interest as a potential pro-ageing factor, leading to speculation about its involvement in muscle metabolism and the development of sarcopenia, a key component of...
25.
Yu X, Chen X, Wu W, Tang H, Su Y, Lian G, et al.
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13771. PMID: 40026072
Background: Muscle atrophy is a severe complication of diabetes, with autophagy playing a critical role in its progression. Zinc has been shown to alleviate hyperglycaemia and several diabetes-related complications, but...
26.
Ng K, Macdonald J, Young R, March D, Graham-Brown M, Mercer T, et al.
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13748. PMID: 40026059
Background: Haemodialysis patients are at high risk of myopenic obesity, necessitating effective nutritional status monitoring and intervention strategies. This combined analysis of two clinical trials (PEDAL trial and CYCLE-HD study)...
27.
Fielding R, Dao M, Cannon K, Desvarieux M, Miller S, Gimness M, et al.
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13750. PMID: 40026058
Background: Sarcopenia is a progressive muscle disorder that may lead to mobility disability. No pharmaceutical interventions are currently available, and treatment relies on physical exercise and nutrition. The aim of...
28.
Imani M, Buratto J, Dao T, Meijering E, Vogrin S, Kwok T, et al.
J Cachexia Sarcopenia Muscle . 2025 Mar; 16(2):e13728. PMID: 40022453
Background: Age-related conditions, such as osteoporosis and sarcopenia, alongside chronic diseases, can result in significant musculoskeletal tissue loss. This impacts individuals' quality of life and increases risk of falls and...
29.
Kronenberger D, Zimmers T, Ralston R, Runco D
J Cachexia Sarcopenia Muscle . 2025 Feb; 16(2):e13712. PMID: 40019842
Background: Growth Differentiation Factor 15 (GDF15), a nonspecific inflammatory marker and member of the TGF-β superfamily, has a well-established role in both inflammation and metabolic modulation, but lacks a comprehensive...
30.
Bowers M, Petrasso C, McLuskie A, Bayly J, Laird B, Higginson I, et al.
J Cachexia Sarcopenia Muscle . 2025 Feb; 16(2):e13716. PMID: 40012451
Background: Cancer cachexia has substantial impacts on people's quality of life. There is no current gold standard treatment, but the complex pathophysiology of cachexia suggests that a multitargeted and individualised...